lenalidomide,rituximab,acalabrutinib
astrazeneca
['lenalidomide', 'ritux', 'acalabrutinib', ' lena', 'imab ']
impressive results of chemotherapy-free regimen of acalabrutinib, lenalidomide and rituximab in treatment naive mcl by ruan et al. n=24, orr 100%, cr 83%. mrd negative pb 67% at 12 cycles and 83% at the end of maintenance. #ash22